MoFo News Item

MoFo Advises Ally Bridge Group on Investment in Imperative Care

17 Dec 2019

Morrison & Foerster advised Ally Bridge Group in connection with a Series C financing round totaling $85 million in Imperative Care, an innovative startup that is dedicated to improving the way ischemic and hemorrhagic strokes are treated. Announced on December 10, 2019, the round was co-led by Ally Bridge and Bain Capital Life Sciences. This marks the third investment that MoFo has closed on behalf of Ally Bridge since April 2019.

Founded in 2016 by Dr. Nick Hopkins, a pioneer of endovascular neurointervention, and medtech entrepreneur Fred Khosravi, Imperative Care is developing a portfolio of solutions to address the vast and urgent unmet needs in stroke care. The company says it will use the funds to support the commercial launch of its breakthrough technologies.

The cross-border, cross-practice MoFo team was led by Hong Kong corporate partner Thomas Chou and included corporate associates Cecile Yang in Hong Kong and Connor Acle and Olga Terets in San Francisco, patent partner Janet Xiao and associate John Chapman in Palo Alto, and FDA regulatory partner Bethany Hills in New York.

Read the related press release.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.